Skip to main content

Advertisement

Log in

Agalactosyl IgG is elevated in patients with active spondyloarthropathy

  • ORIGINAL ARTICLE
  • Published:
Rheumatology International Aims and scope Submit manuscript

Abstract

Patients with rheumatoid arthritis or with Crohn's disease have deficient galactosylation of serum IgG [Gal(0)]. To study whether such deviation occurs in patients with spondyloarthropathy (SPA), we studied the percentage incidence of Gal(0) corrected for age [Gal(0)corr] in 47 SPA patients undergoing ileocolonoscopy and correlated the findings with clinical variables and prognosis of the patients. Gal(0)corr was elevated in 36% of the patients. Such patients had a higher number of inflamed joints (P<0.02), higher ESR (P<0.001) and CRP (P<0.001). Elevated Gal(0)corr was also of prognostic significance: at 6-month follow-up those with elevated levels had a higher number of inflamed joints (P<0.02) and ESR (P<0.05). The presence of high Gal(0)corr did not associate with gut inflammation. In conclusion, a proportion of SPA patients has elevated levels of Gal(0), the amount of which correlates with severity of the disease and is a prognostic marker for chronicity of the disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Additional information

Received: 9 July 1998 / Accepted: 14 January 1999

Rights and permissions

Reprints and permissions

About this article

Cite this article

Leirisalo-Repo, M., Hernandez-Munoz, H. & Rook, G. Agalactosyl IgG is elevated in patients with active spondyloarthropathy. Rheumatology International 18, 171–176 (1999). https://doi.org/10.1007/s002960050080

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s002960050080

Navigation